According to the latest report by IMARC Group, titled " Antifungal Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global antifungal drugs market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 4% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/antifungal-drugs-market/requestsample
Antifungal drugs are generally used to treat and prevent mycosis, including ringworm, athlete’s foot, cryptococcal meningitis and candidiasis. Fungal infections are commonly caused by various types of yeasts, such as dermatophytes, trichophyton and candida, that cause irritation, rashes, loss of color, deformed toenail, and vaginal discharge in patients. Some of the commonly prescribed antifungal drugs include fluconazole, econazole, econazole and terbinafine.
The global market is primarily driven by significant growth in the pharmaceutical sector. Along with this, the increasing investments by public and private firms to upgrade the existing healthcare infrastructure across the globe are creating a positive outlook for the market. Moreover, continual product innovations, such as the introduction of synthetic azole-based compounds to treat invasive superficial and fungal infections, are providing an impetus to the market growth. Some of the other factors contributing to the market growth include extensive research and development (R&D) activities conducted by key players to launch antifungal drugs variants in the form of sprays, injections and creams.
Antifungal Drugs Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global antifungal drugs market has been studied in the report with the detailed profiles of the key players operating in the market.
Competitive Landscape with Key Players:
- Abbott Laboratories
- Arcadia Consumer Healthcare Inc.
- Astellas Pharma Inc.
- Bayer AG
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Scynexis Inc.
Key Market Segmentation:
The report has segmented the global antifungal drugs market on the basis of drug class, indication and region.
Breakup by Drug Class:
Breakup by Indication:
Breakup by Region:
- North America
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://bit.ly/3Ewn7L3
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800